T0	Participants 74 95	postmenopausal women.
T1	Participants 300 410	normotensive postmenopausal women receiving a fixed mid-range daily dose of conjugated equine oestrogen (CEE).
T2	Participants 433 495	Twenty normotensive postmenopausal women (median age 53 years)